Clinerion files patent for anonymized patient identification tech

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Tashatuvango)
(Image: iStock/Tashatuvango)

Related tags: Patent

Clinerion has filed a patent for a technology that matches anonymized records with corresponding hospital medical records to identify potential clinical trial participants.

The patent was filed at the European Patent Office (EPA).

According to the company, the “anonymized identification” (ANID) technology exclusively uses anonymized data. Implemented in Clinerion’s Patient Recruitment System (PRS), the new technology reduces the risk of private information being revealed.

Though the technology uses anonymized records, it allows authorized clinical trial managers at the hospital to re-identify eligible patients.

The system’s set-up features a one-way, outbound-only connection between the hospital IT infrastructure and the Clinerion PRS server, which is locally hosted.

Moving forward, all new PRS installations will use the technology and existing installations will be migrated on request.

As Outsourcing-Pharma.com previously reported​, the company has been expanding its PRS platform and has recently rolled out​ its services to countries in EEMEA.

Clinerion’s patient data services include data-assisted protocol optimization, site feasibility evolution, and patient identification.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars